TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Unrecognized Tax Benefits in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Teva Pharmaceutical Industries Ltd quarterly Unrecognized Tax Benefits history and growth rate from Q4 2010 to Q4 2023.
  • Teva Pharmaceutical Industries Ltd Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $651M, a 2.04% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $651M +$13M +2.04% Dec 31, 2023 10-K 2024-02-12
Q4 2022 $638M -$34M -5.06% Dec 31, 2022 10-K 2024-02-12
Q4 2021 $672M -$216M -24.3% Dec 31, 2021 10-K 2024-02-12
Q4 2020 $888M -$335M -27.4% Dec 31, 2020 10-K 2024-02-12
Q4 2019 $1.22B +$151M +14.1% Dec 31, 2019 10-K 2023-02-10
Q4 2018 $1.07B +$38M +3.68% Dec 31, 2018 10-K 2022-02-09
Q4 2017 $1.03B +$300M +40.9% Dec 31, 2017 10-K 2021-02-10
Q4 2016 $734M +$86M +13.3% Dec 31, 2016 10-K 2020-02-21
Q4 2015 $648M -$65M -9.12% Dec 31, 2015 10-K 2018-02-12
Q4 2014 $713M +$48M +7.22% Dec 31, 2014 10-K 2018-02-12
Q4 2013 $665M -$238M -26.4% Dec 31, 2013 20-F 2017-02-15
Q4 2012 $903M -$4M -0.44% Dec 31, 2012 20-F 2016-02-11
Q4 2011 $907M +$112M +14.1% Dec 31, 2011 20-F 2015-02-09
Q4 2010 $795M Dec 31, 2010 20-F 2014-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.